Azelastine Allergen Chamber - Onset of Action Study

Clinical trial NCT06126952 · COMPLETED

Trial details

NCT number: NCT06126952
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2023-10-30
Primary completion: 2024-02-23
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.